Quarterly report pursuant to Section 13 or 15(d)

Net Income (Loss) Per Share (Schedule Of Earnings Per Share, Basic And Diluted) (Details)

v3.20.4
Net Income (Loss) Per Share (Schedule Of Earnings Per Share, Basic And Diluted) (Details) - USD ($)
3 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Schedule of Earnings Per Share, Basic and Diluted [Line Items]    
Net income (loss) $ 17,227,701 $ (3,305,101)
Basic weighted average common shares outstanding 70,313,589 65,038,511
Common stock purchase warrants 1,025,580  
Total net effect of dilutive instruments 5,485,448  
Diluted weighted average common shares outstanding 75,799,037 65,038,511
Net income (loss) per basic common share outstanding $ 0.25 $ (0.05)
Net income (loss) per diluted common share outstanding $ 0.23 $ (0.05)
Options [Member]    
Schedule of Earnings Per Share, Basic and Diluted [Line Items]    
Net effect of dilutive instruments 4,421,341  
Stock Appreciation Rights (SARs) [Member]    
Schedule of Earnings Per Share, Basic and Diluted [Line Items]    
Net effect of dilutive instruments 38,527